The evolution of monitoring: from 100% SDV to risk-based approaches

Free Lesson Preview

This is just the beginning

The full CRC track covers 8 courses from study start-up to close-out — the skills sponsors actually look for.

Already enrolled? Sign in

Two mornings, twenty years apart

It is 2004. A coordinator at a research site in Kansas City, Missouri, arrives at work on a Monday to find a familiar message from the monitor: the next visit is scheduled for Thursday, and the monitor will need every participant chart pulled. All of them. There are 47 active participants across two treatment arms of a Phase III trial, and the monitor intends to review source data for every single one. The coordinator will spend the next three days pulling medical records, printing laboratory reports, organizing consent forms by date, and stacking binders on a conference table so that the monitor can work through them, page by page, checking every data point against the case report form. The visit will take two and a half days. Much of what the monitor reviews will be entirely unremarkable--vital signs that match the electronic data capture perfectly, concomitant medication lists that have not changed since the last visit, visit dates that line up exactly with the schedule. But the monitor will check them all, because that is what monitoring means.

Now it is 2025. A coordinator at that same site receives a different kind of communication. The monitor sends a targeted agenda: this visit will focus on five participants who were recently enrolled, two participants with protocol deviations flagged by centralized data analytics, and the informed consent process for a newly approved protocol amendment. The regulatory binder review will concentrate on the updated delegation log and training records for the new sub-investigator. The visit will take one day. The coordinator knows exactly what to prepare, and the preparation is focused rather than exhaustive.

The distance between these two mornings is not merely a story about efficiency gains or technology adoption. It is a story about a fundamental shift in how the clinical trial enterprise thinks about quality--a shift from the assumption that checking everything catches everything to the recognition that intelligent, risk-proportionate oversight protects participants and data integrity more effectively than brute-force verification ever did.

This is your final course in the CRC Professional Track, and it begins here: with understanding how monitoring evolved, why it changed, and what this transformation means for the work you do every day.